Biochemist Anna Pertl used an AI tool called Co-Scientist to tackle a complex cancer problem. Unlike typical chatbots, Co-Scientist employs multiple AI agents to explore scientific hypotheses, requiring significant computational power and time. Pertl sought innovative ways to target MYC, a protein linked to many cancers, by leveraging molecular droplets called condensates. Her supervisor, Richard Young, had previously discovered how cancer cells use these condensates to activate MYC. Pertl and bioengineer Kalon Overholt worked with Co-Scientist to refine their question, leading the AI to analyze over 700 papers and propose 108 strategies, ultimately suggesting a novel approach. This AI-driven method challenges existing ideas and could revolutionize cancer treatment strategies.
QUESTION: How might AI tools like Co-Scientist change the future of scientific research and innovation?
